Pacific Biosciences Of California (PACB) EPS (Basic) (2010 - 2026)
Pacific Biosciences Of California's (PACB) quarterly EPS (Basic) came in at -$0.03 in Q1 2026, up 98.11% year-on-year from -$0.01 in Q1 2025, and up 79.9% quarter-over-quarter from -$0.13 in Q4 2025.
Pacific Biosciences Of California (PACB) EPS (Basic) (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.03 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 98.11% year-over-year to -$0.03 in Q1 2026; TTM through Mar 2026 was -$0.42, a 81.02% increase from a year earlier, with the FY2025 full-year figure at -$1.82, down 61.36% from the prior year.
- EPS (Basic) improved to -$0.03 in Q1 2026 per PACB's latest filing, from -$0.13 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.01 in Q4 2024 and bottomed at -$1.44 in Q1 2025.
- The 5-year median for EPS (Basic) is -$0.29 (2024), against an average of -$0.33.
- Across the five-year window, EPS (Basic) jumped 102.67% in 2024 and sank 1658.11% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.38 in 2022, then increased by 13.95% to -$0.32 in 2023, then jumped by 102.67% to $0.01 in 2024, then sank by 1658.11% to -$0.13 in 2025, then surged by 79.9% to -$0.03 in 2026.
- Per Business Quant, the three latest PACB EPS (Basic) figures stand at -$0.03 (Q1 2026), -$0.13 (Q4 2025), and -$0.13 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Pacific Biosciences Of California | 428.15 Mn | 152.18 Mn | 12.84 Mn | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | -0.13 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -1.44 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | -0.22 |
| Jun 30, 2024 | -0.64 |
| Mar 31, 2024 | -0.29 |
| Dec 31, 2023 | -0.32 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.36 |
| Dec 31, 2022 | -0.38 |
| Sep 30, 2022 | -0.34 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -0.37 |
| Dec 31, 2021 | -0.34 |
| Jun 30, 2021 | -0.44 |
| Mar 31, 2021 | -0.20 |